Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9551
Title: Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes.
Authors: Johnston, Colin I;Cooper, Mark E;Nicholls, G M
Affiliation: Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
Issue Date: 1-Apr-1992
Citation: Journal of Hypertension; 10(4): 393-7
Abstract: Points of agreement: (1) In IDDM, hypertension occurs in patients who have already developed nephropathy, probably in the microalbuminuric phase. (2) Hypertension is an important accelerator of the development of diabetic nephropathy. (3) Hypertension, obesity and NIDDM are often associated, and insulin resistance is commonly observed in all three states. (4) Antihypertensive therapy retards the development of diabetic nephropathy in IDDM and reduces proteinuria in NIDDM. (5) The choice of antihypertensive agent in the diabetic patient must be based upon the efficacy of the drug as well as avoidance of side effects including deleterious influence on glucose, insulin and lipid levels and renoprotection. (6) Carefully conducted long-term comparative trials between different classes of antihypertensive drugs in microalbuminuric IDDM and NIDDM patients are essential. Points of major controversy: (1) Detection of IDDM patients prone to the development of diabetic nephropathy can be performed by measuring specific parameters such as erythrocyte Na(+)-Li+ countertransport activity. (2) Insulin resistance is a pathogenic mechanism rather than purely an association with hypertension and obesity. (3) A certain class of antihypertensive agents--ACE inhibitors--confers a specific renoprotective effect in diabetic nephropathy, in addition to its effects upon systemic blood pressure. (4) Reduction of blood pressure should be considered in the normotensive microalbuminuric diabetic patient. (5) Microalbuminuria is a sufficient 'surrogate endpoint' for the progression of renal failure.
Internal ID Number: 1316406
URI: http://ahro.austin.org.au/austinjspui/handle/1/9551
URL: http://www.ncbi.nlm.nih.gov/pubmed/1316406
Type: Journal Article
Subjects: Animals
Antihypertensive Agents
Diabetes Mellitus
Diabetes Mellitus, Experimental
Diabetic Nephropathies
Humans
Hypertension
Rats
Rats, Inbred SHR
Societies, Medical
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.